Quoin Pharmaceuticals (QNRX) Total Current Liabilities (2017 - 2026)
Quoin Pharmaceuticals (QNRX) posted Total Current Liabilities of $5.3 million for Q1 2026, down 3.62% sequentially from $5.5 million in Q4 2025, and up 10.1% YoY from $4.9 million in Q1 2025.
Quoin Pharmaceuticals (QNRX) Total Current Liabilities (2017 - 2026) Analysis & Trends
Quoin Pharmaceuticals has reported Total Current Liabilities for 10 years, with the latest figure at $5.3 million in Q1 2026.
- Quarterly Total Current Liabilities rose 10.1% year-over-year to $5.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.3 million (up 10.1% YoY) and the FY2025 annual result came in at $5.5 million, up 32.67% from the prior year.
- Total Current Liabilities fell to $5.3 million in Q1 2026 per QNRX's latest filing, from $5.5 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $5.8 million in Q3 2025 and troughed at $3.5 million in Q3 2024.
- A 5-year average of $4.3 million and a median of $4.2 million in 2024 frame the typical range for Total Current Liabilities.
- The sharpest annual moves came in 2024 and 2025: Total Current Liabilities dropped 24.16% in 2024, then surged 65.95% in 2025.
- Over 5 years, Total Current Liabilities stood at $3.5 million in 2022, then grew by 1.53% to $3.6 million in 2023, then advanced by 16.74% to $4.2 million in 2024, then jumped by 32.67% to $5.5 million in 2025, then declined by 3.62% to $5.3 million in 2026.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $5.3 million, $5.5 million, and $5.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.58 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 2.53 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 2.12 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.51 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 438.74 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 630.93 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 2.49 Bn |
| 10 | Quoin Pharmaceuticals | 491,038.58 | 491,038.58 | - | 6.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.35 Mn |
| Dec 31, 2025 | 5.55 Mn |
| Sep 30, 2025 | 5.76 Mn |
| Jun 30, 2025 | 4.34 Mn |
| Mar 31, 2025 | 4.86 Mn |
| Dec 31, 2024 | 4.18 Mn |
| Sep 30, 2024 | 3.47 Mn |
| Jun 30, 2024 | 3.95 Mn |
| Mar 31, 2024 | 4.22 Mn |
| Dec 31, 2023 | 3.58 Mn |
| Sep 30, 2023 | 4.58 Mn |
| Jun 30, 2023 | 4.41 Mn |
| Mar 31, 2023 | 4.16 Mn |
| Dec 31, 2022 | 3.53 Mn |
| Sep 30, 2022 | 3.60 Mn |
| Jun 30, 2022 | 3.67 Mn |
| Dec 31, 2021 | 4.58 Mn |
| Dec 31, 2020 | 929,000.00 |
| Jun 30, 2020 | 863,000.00 |
| Jun 30, 2019 | 1.30 Mn |